Phocas Financial’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARQT
Phocas Financial's ARQT Position: Q3 2026 in Review
Phocas Financial sold out of Arcutis Biotherapeutics (ARQT) in Q3 2026, closing a stake of 47,746 shares — an estimated $1.25M sold.
Phocas Financial first reported a position in ARQT in Q1 2025 and held it in 6 quarters. The position peaked at $2M in Q3 2025. 293 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.
- Phocas Financial reported no remaining Arcutis Biotherapeutics position as of Q3 2026 after selling out during the quarter.
- Phocas Financial sold 47,746 Arcutis Biotherapeutics shares in Q3 2026, an estimated $1.25M.
- Phocas Financial first reported a position in Arcutis Biotherapeutics in Q1 2025 and held it in 6 quarters.
- Phocas Financial's Arcutis Biotherapeutics position peaked at $2M in Q3 2025.
- 293 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.
Based on Phocas Financial's 13F filing for Q3 2026.